Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aristocaths ethanol lock study in pediatric oncology
NL-OMON22330Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in catheter-associated bloodstream infection (CRBSI) comparing Ethanol 70% arm with Heparin 100 U/ml arm (2 arms). Primary endpoint: Primary composite endpoint. Started Oct 2007; status: recruiting.
02
Drugs
ethanolheparin
03
Conditions
catheter-associated bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NL-OMON22330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22330.